The 3rd International Congress on Clinical Trials in Oncology & Hemato-Oncology (ICTO 2019) covers topics such as:
- Personalized cancer medicine
- Design of clinical trials in the new era
- Monitoring of Trials and Statistics
- Immuno-oncology - End Point with Immunotherapy
- Phase 4 Trials
- Regulations – Survival based Medicine
- Ethics and Patients’ Rights
- Expanded access trials
- How to design a Clinical Trial
- Healthcare economy
- Side Effects
- End Point with Immunotherapy
The 3rd International Congress on Clinical Trials in Oncology & Hemato-Oncology (ICTO 2019) brings together:
- Clinical Trial Pharmacists and Investigators
- Study Coordinators
- Hematologists
- Pediatric Clinical Trial Oncologists
- R&D personnel
- Medical Professionals
- CROs / CRAs
- Regulatory Affairs Specialists
- Research Facility Managers
- QA personnel
- Pharmaceutical Company Representatives
